Newark, DE, United States of America

Pingli Liu

This inventor holds 37 USPTO granted patents and 15 published patent applications, plus 10 CIPO patents and 13 EPO patents, primarily in JAK Inhibitor Development. Top assignees: Incyte Corporation, Incyte Holdings Corporation, Basilea Pharmaceutica Ag. Active years: 2002-2025.

USPTO Granted Patents = 37 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 6.2

ph-index = 12

Forward Citations = 662(Granted Patents)


Location History:

  • Wilmington, DE (US) (2002 - 2024)
  • Newark, DE (US) (2013 - 2024)

Company Filing History:


Years Active: 2002-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
JAK Inhibitor
BET Inhibitor
PD-1 Inhibitor
Crystalline Forms
Salts
Intermediates
Processes
Pyrazolyl Compounds
Indoleamine Inhibitors
Amorphous Forms
Quinoline Derivatives
Pyrrolo Compounds
37 patents (USPTO):Explore Patents

Title: Pingli Liu: Pioneering Inventor from Newark

Introduction: Pingli Liu is a trailblazing inventor based in Newark, DE, known for her innovative contributions to various fields.

Latest Patents: Pingli Liu holds several patents in the areas of renewable energy technologies, sustainable materials, and advanced healthcare devices.

Career Highlights: With a background in engineering and a passion for sustainability, Pingli Liu has led groundbreaking projects that have revolutionized the way we approach environmental challenges.

Collaborations: Throughout her career, Pingli Liu has collaborated with leading research institutions, universities, and companies to bring her inventions to life and make a positive impact on society.

Conclusion: Pingli Liu's dedication to innovation and her commitment to creating a better future through her inventions make her a true inspiration in the world of technology and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…